Вы находитесь на странице: 1из 4

IOL Chemicals & Pharmaceuticals Ltd.

Company Report Card-Standalone

Trident Complex,Rajkot Road,Barnala,148101,Punjab

Phone : +91-1679- 244701 244702 244703 / 04 / 05 / 06 / 0

Stock Cues
Latest Price (INR) 51.5 52 Week (High-Low) 113.9-42.2
1 Day Return% -2.92 1 Year Return% -49.68
Market Capitalization 1092.66 Daily Vol (BSE) 27692
Enterprise Value 3495.96 Daily Vol (NSE)
Free Float % 46.35 Beta 0.48
Total No of Shares 18150000 Face Value (INR) 10
TTM EPS 7.04 Book Value 51.75
TTM PE 7.31 Dividend Yield% 0
Bloomberg Code ICP IN Reuters Code IOLC.BO
Quarterly Analysis
Particulars 200912 200812 Var%
Total Sales 862.24 677.63 27.24
Total Expenditure 734.44 608.51 20.69
PBIDT (Excl OI) 127.8 69.12 84.9
PAT 63.88 8.58 644.52
PBIDTM% (Excl OI) 14.82 10.2 45.29
PBIDTM% 14.83 10.21 45.25
PATM% 7.41 1.27 483.46

EPS (INR) 3.01 0.48 527.08

Shareholding Pattern (Dec-2009)


Company Report Card-Standalone (Industry-Chemicals )

dent Complex,Rajkot Road,Barnala,148101,Punjab

: +91-1679- 244701 244702 244703 / 04 / 05 / 06 / 07


INR Millions

Description 200903 200803 200703 200603 200503


Inc / Exp Performance
Net Sales 3018.58 3179.43 2025.94 1529.79 841
Growth% -5.06 56.94 32.43 81.9
Total Income 3051.94 3183.05 2027.51 1532.15 843.35
Total Expenditure 2691.75 2815.51 1839.16 1352.04 759.94
PBIDT 360.19 367.54 188.35 180.1 83.41
Growth% -2 95.14 4.58 115.92
PBIT 260.17 293.25 153.46 152.78 61.74
PBT 110.98 163.67 86.99 97.25 26.74
PAT 126.94 123.63 75.51 72.57 56.12
Growth% 2.68 63.73 4.05 29.31
Cash Profit 226.96 197.92 110.4 99.9 77.79
Sources of Funds
Equity Paid Up 181.5 133.8 94.5 80.5 80.5
Reserves and Surplus 793.93 478.05 185.81 47.3 -25.27
Net Worth 975.43 609.26 275 123.48 48.58
Total Debt 2470.25 1133.24 1024.11 546.99 370.47
Capital Employed 3585.68 1839.72 1349.1 728.17 469.05
Application of Funds
Gross Block 1591.53 1527.75 962.48 510.7 430.28
Investments 0 0 0 0 0
Cash and Bank balance 66.95 37.34 33.82 24.05 10.5
Net Current Assets 505.56 352.61 220.68 186.48 125.36
Total Current Liabilities 586.15 528.35 410.1 214.02 125.12
Total Assets 3585.68 1842.3 1354.42 732.5 475.69
Cash Flow
Cash Flow from Operations 214.51 223.61 154.06 112.3 32.38
Cash Flow from Investing activities -1670.04 -469.22 -643.67 -238.34 -68.59
Cash Flow from Finance activities 1485.13 249.12 499.38 139.6 40.8
Free Cash flow -1336.4 -165.32 -518.49 -96.75 52.85
Key Ratios
Debt to Equity(x) 2.14 2.19 3.15 3.37 4.84
Current Ratio(x) 1.89 1.68 1.55 1.89 2
ROCE(%) 9.59 18.39 14.77 25.52 15.25
RONW(%) 16.02 27.96 37.9 84.36 289.78
PBIDTM(%) 10.78 10.18 8.13 10.32 8.64
PATM(%) 3.8 3.42 3.26 4.16 5.81
CPM(%) 6.79 5.48 4.76 5.73 8.06
Market Cues
Close Price (Unit Curr.) 94 118 36.7 63 21.9
High Price (Unit Curr.) 173 220 75.4 87 25.4
Low Price (Unit Curr.) 80.55 33.5 33.9 20.75 2.5
Market Capitalization 1706.1 1578.84 346.82 507.15 176.3
EPS 6.99 9.24 7.99 9.02 6.97
Price / Book Value(x) 1.75 2.59 1.26 4.11 3.63
CEPS 12.5 14.79 11.68 12.41 9.66
Equity Dividend % 0 0 0 0 0
Enterprise Value 4159.4 2724.75 1387.1 1080.09 586.26
Dividend Yield % 0 0 0 0 0
Valuation Ratio
PER(x) 13.44 12.77 4.59 6.99 3.14
PCE(x) 7.52 7.98 3.14 5.08 2.27
Price / Book Value(x) 1.75 2.59 1.26 4.11 3.63
Dividend Yield(%) 0 0 0 0 0
EV/Net Sales(x) 1.38 0.86 0.68 0.71 0.7
EV/Core EBITDA(x) 11.55 7.41 7.36 6 7.03
EV/EBIT(x) 15.99 9.29 9.04 7.07 9.5
EV/CE(x) 1.16 1.48 1.02 1.47 1.23

M Cap / Sales 0.57 0.5 0.17 0.33 0.21